<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Chemistry on NIH Data Science SIG</title>
    <link>https://nihdatasciencesig.github.io/tags/chemistry/</link>
    <description>Recent content in Chemistry on NIH Data Science SIG</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <managingEditor>seandavi@gmail.com (NIH Data Science SIG)</managingEditor>
    <webMaster>seandavi@gmail.com (NIH Data Science SIG)</webMaster>
    <lastBuildDate>Wed, 07 Mar 2018 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="https://nihdatasciencesig.github.io/tags/chemistry/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Translating from Chemistry to Clinic with Deep Learning</title>
      <link>https://nihdatasciencesig.github.io/event/2018/03/07/translating-from-chemistry-to-clinic-with-deep-learning/</link>
      <pubDate>Wed, 07 Mar 2018 00:00:00 +0000</pubDate>
      <author>seandavi@gmail.com (NIH Data Science SIG)</author>
      <guid>https://nihdatasciencesig.github.io/event/2018/03/07/translating-from-chemistry-to-clinic-with-deep-learning/</guid>
      <description>NLM Informatics and Data Science Lecture Series
Abstract: Many medicines become toxic only after bioactivation by metabolizing enzymes. Often, metabolic enzymes transformed them into chemically reactive species, which subsequently conjugate to proteins and cause adverse events. For example, carbamazepine is epoxidized by P450 enzymes in the liver, but then conjugates to proteins, causing Stevens Johnson Syndrome in some patients. The most difficult to predict drug reactions, idiosyncratic adverse drug reactions, often depend on bioactivation.</description>
    </item>
    
  </channel>
</rss>